Prognostic disclosure in oncology-current communication models: a scoping review
JR Bloom, DC Marshall… - BMJ supportive & …, 2022 - spcare.bmj.com
Background Prognostic disclosure is essential to informed decision making in oncology, yet
many oncologists are unsure how to successfully facilitate this discussion. This scoping …
many oncologists are unsure how to successfully facilitate this discussion. This scoping …
[HTML][HTML] A scoping review of interactive and personalized web-based clinical tools to support treatment decision making in breast cancer
The increasing attention on personalized breast cancer care has resulted in an explosion of
new interactive, tailored, web-based clinical decision tools for guiding treatment decisions in …
new interactive, tailored, web-based clinical decision tools for guiding treatment decisions in …
[HTML][HTML] Integrated analysis of the clinical consequence and associated gene expression of ALK in ALK-positive human cancers
T Tsukahara - Heliyon, 2022 - cell.com
Anaplastic lymphoma kinase (ALK) is a tyrosine kinase receptor that is genetically altered in
several cancers, including NSCLC, melanoma, lymphoma, and other tumors. Although ALK …
several cancers, including NSCLC, melanoma, lymphoma, and other tumors. Although ALK …
Patient-centered outcomes for gastrointestinal cancer care: a scoping review protocol
Introduction Following a cancer diagnosis, patients and their caregivers face crucial
decisions regarding goals of care and treatment, which have consequences that can persist …
decisions regarding goals of care and treatment, which have consequences that can persist …